SOHONOS
These highlights do not include all the information needed to use SOHONOS™ safely and effectively. See full prescribing information for SOHONOS. SOHONOS (palovarotene) capsules, for oral use Initial U.S. Approval: 2023
67dce406-7cc4-4d66-92de-ad18b6df0625
HUMAN PRESCRIPTION DRUG LABEL
Aug 24, 2023
Ipsen Biopharmaceuticals, Inc.
DUNS: 118461578
Products 5
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
palovarotene
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (13)
palovarotene
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (13)
palovarotene
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (13)
palovarotene
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (13)
palovarotene
Product Details
FDA regulatory identification and product classification information